Robert Lorne Hopfner has bought stock on 4 days since Aug 2021
Director at Inozyme Pharma, Inc., and 2 other companies
SEC CIK 0001551966 · Filings on SEC.gov ↗
Robert Lorne Hopfner's record
3 months after each buy, from the first price a copier could get.
4 buys since 2021 with 3 months of prices.
Companies
Every filing
12 filings since Jan 2021, newest first
Inozyme Pharma, Inc.
Director
Inozyme Pharma, Inc.
Director
Inozyme Pharma, Inc.
Director
Rallybio Corp
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
Vaxcyte, Inc.
Director
About Robert Lorne Hopfner
Robert Lorne Hopfner is a Person and serves as a director of Inozyme Pharma, Inc., where he has appeared in SEC insider filings as a reporting person and board member.( He is also a Managing Partner at Pivotal bioVenture Partners, focusing on drug discovery and development investments, and has been identified in company materials as having board responsibilities across multiple life sciences companies, including Inozyme Pharma, Vaxcyte, and Rallybio.(
Hopfner’s professional background is rooted in biotechnology investing and governance. Public investor and company sources describe him as RPh, PhD, MBA, indicating training in pharmacy, advanced research, and business administration.( Available materials do not provide a full career chronology or detailed education history, but they do show that he has held senior investment and board roles in the life sciences sector and was added to Inozyme Pharma’s board in connection with the company’s financing and growth efforts.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.